Abstract
Breast cancer is one of the major public health concerns affecting women worldwide and is the leading cause of cancer-related mortality among women. In the Democratic Republic of the Congo (DRC), its management remains a major challenge, particularly due to limited public awareness, inadequate diagnostic and therapeutic resources, and restricted access to screening services. This study aimed to assess the prevalence of breast cancer in the Kalamu Health Zone, Kinshasa. A retrospective cross-sectional study was conducted at the LEBOMA Laboratory between May 2024 and May 2025. Of the 436 cancer cases recorded, 184 were breast cancers, representing a proportion of 42.2%. Women accounted for 99.5% of these cases, with a mean age of 45.5 years. Histologically, invasive ductal carcinoma was the predominant type, accounting for 92.4% of cases. These findings highlight the substantial proportion of breast cancer among the cancer cases recorded at this facility and underscore the need to strengthen awareness campaigns, early detection strategies, and access to diagnostic and treatment services.
References
1. Asoogo C, Duma SE. (2015). Factors contributing to late breast cancer presentation for health care amongst women in Kumasi, Ghana. Curationis. 31;38(1):1287. doi: 10.4102/curationis.v38i1.1287
2. Bray F, Ferlay J, Soerjomataram, Siegel RL, Torre LA, Jemal A. (2018). Global cancer Statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J clin. 68 (6):394-424.
3. Donkor, A., Lathlean, J., Wiafe, S., Vanderpuye, V., Fenlon, D., Yarney, J., Opoku, S.Y., Antwi, W. and Kyei, K.A. (2015). Factors contributing to late presentation of breast cancer in Africa: a systematic literature review. Archives of Medicine, 8 (2.2), 1-10.
4. Global Cancer Observatory. International Agency for Research on cancer. Cancer Tomorrow, 2022. https://gco.iarc.who.int/en.
5. Ingala PJA, Salamo MA, Dienga ET, Longaga SL, Panzi EK, Ombha EL. (2024). Résultats des connaissances sur cancer du sein chez les femmes congolaises à Kinshasa : une étude transversale. PAMJ Clinical Medicine. 14:13. doi: 10.11604/pamj-cm.2024.14.13.41634.
6. Lukong KE, Ogunbolude Y, Kamdem JP. (2017). Breast cancer in Africa: prevalence, treatment options, herbal medicines, and socioeconomic determinants. Breast Cancer Res Treat. 166(2):351-365. doi: 10.1007/s10549-017-4408-0
7. Majidi A, Majidi S, Salimzadeh S, Pool MK, Sadjadi A, Salimzadeh H, Delavari A. (2017). Cancer Screening Owareness and practice in middle income country: A Systematic review from I ram. Asian paC J cancer prev. 18 :3187-3194. doi: 10.220 34/ APJCP. 2017. 18.
8. Mbala K, Tozin R, Mbala N, Kamba B, Sinamuli K, Omanga U. (2019). Profil épidémio-clinique et moléculaire du cancer du sein dans les hôpitaux de la ville Kinshasa-RD. Congo. Kismed 9(1), 326-332.
9. Menon G, Alkabban FM, Ferguson T. Breast Cancer. (2024). In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2024 Jan–PMID: 29493913.
10. Nambile S, Nkeh K, Tsoka-gwegweni JM, Africa S. (2017). Breast cancer among women in sub-Saharan Africa: Prevalence and a situational analysis. Southern African Journal of Gynaecological Oncology. 9(2):35–37. doi: 10.1080/20742835.2017.1391467.
11. Organisation mondiale de la santé. Cancer du sein, politique de confidentialité. OMS, 2023, Génève.
12. Ouédraogo, NA, Ouattara A, Bambara A, et al. (2019). Profil mammo-échographique et histopathologique des cancers du sein de la femme à Ouagadougou (Burkina Faso) Journal Africain de l'Imagerie Médicale, 11(1): 274-278.
13. Sancho-Garnier H, Colonna M. (2019). Breast cancer epidemiology. Presse Med. 48(10):1076-1084. doi: 10.1016/j.lpm.2019.09.022.
14. Sulu SMM, Mukuku O, Sulu AMS, Massamba BL, Mashinda DK, Tshimpi AW. (2023). Knowledge regarding breast cancer among Congolese women in Kinshasa, Democratic Republic of the Congo. Cancer Rep (Hoboken). 6(3):e1758. doi: 10.1002/cnr2.1758
15. Xiong X, Zheng LW, Ding Y, Chen YF, Cai YW, Wang LP, Huang L, Liu CC, Shao ZM, Yu KD. (2025). Breast cancer: pathogenesis and treatments. Signal Transduct Target Ther. 19;10(1):49. doi: 10.1038/s41392-024-02108-4.

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Copyright (c) 2026 Bolungu et al.
